Protocol Ledger

NCT05417516 · Phase III · RECRUITING

A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

Interventional Phase III clinical trial protocol NCT05417516 sponsored by Ontario Clinical Oncology Group (OCOG) in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-11-20 Enrollment: 910 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05417516
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)910 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05417516
Protocol FieldVerified Registry Value
NCT IdentifierNCT05417516
Consolidated Lead SponsorOntario Clinical Oncology Group (OCOG)
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment910 participants (ESTIMATED)
Registered Start Date2023-11-20
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05417516
Hospital Research SiteLocationSite Profile
McGill University Health CentreMontreal, CanadaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI